The ROE as of December 2024 (TTM) for PaxMedica, Inc. Common Stock (PXMD) is -3167.06%

According to PaxMedica, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -3167.06%. This represents a change of -2139.98% compared to the average of 155.25% of the last 4 quarters.

PaxMedica, Inc. Common Stock (PXMD) Historical ROE (quarterly & annually)

How has PXMD ROE performed in the past?

The mean historical ROE of PaxMedica, Inc. Common Stock over the last ten years is -2203.93%. The current -3167.06% ROE has changed 43.70% with respect to the historical average. Over the past ten years (40 quarters), PXMD's ROE was at its highest in in the September 2023 quarter at 940.41%. The ROE was at its lowest in in the December 2022 quarter at -5018.22%.

PaxMedica, Inc. Common Stock (PXMD) ROE by Quarter and Year

Discovering the peaks and valleys of PaxMedica, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PaxMedica, Inc. Common Stock (PXMD) Average ROE

How has PXMD ROE performed in the past?

The current ROE of PaxMedica, Inc. Common Stock (PXMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

PaxMedica, Inc. Common Stock (PXMD) ROE vs. Peers

How is PXMD’s ROE compared to its peers?

PaxMedica, Inc. Common Stock’s ROE is greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Blue Water Vaccines, Inc. (-126.11%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Hillstream BioPharma, Inc. (-172.28%), greater than Unicycive Therapeutics, Inc. (-374.14%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), greater than Virax Biolabs Group Limited (-115.10%), greater than Allarity Therapeutics, Inc. (-328.22%), less than Kiromic BioPharma, Inc. (327.18%), greater than Biodexa Pharmaceuticals Plc (-101.74%), less than Kiora Pharmaceuticals, Inc. (21.31%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Palisade Bio, Inc. (-148.31%), less than Apexigen, Inc. (48.27%), greater than Immix Biopharma, Inc. (-102.10%),

Build a custom stock screener for PaxMedica, Inc. Common Stock (PXMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PaxMedica, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PaxMedica, Inc. Common Stock (PXMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PaxMedica, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.